Showing 1 - 1 results of 1 for search 'Anthony Fabricatore', query time: 0.02s Refine Results
  1. 1
    Semaglutide 2.4 mg clinical outcomes in patients with obesity or overweight in a real‐world setting: A 6‐month retrospective study in the United States (SCOPE)

    Semaglutide 2.4 mg clinical outcomes in patients with obesity or overweight in a real‐world setting: A 6‐month retrospective study in the United States (SCOPE) by Aleksandrina Ruseva, Wojciech Michalak, Zhenxiang Zhao, Anthony Fabricatore, Bríain Ó. Hartaigh, Devika Umashanker

    Published 2024-02-01
    Get full text
    Article

Search Tools: